<DOC>
	<DOCNO>NCT02438826</DOCNO>
	<brief_summary>The main purpose study evaluate efficacy study drug know LY2951742 participant chronic cluster headache .</brief_summary>
	<brief_title>A Study LY2951742 Participants With Chronic Cluster Headache</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Cluster Headache</mesh_term>
	<criteria>Participants history chronic cluster headache occur without remission period , remission last &lt; 1 month , least 1 year . Participants able distinguish cluster headache attack headache . Current enrollment discontinuation within last 30 day , clinical trial involve investigational drug device . Current use prior exposure calcitoningenerelated peptide ( CGRP ) antibody , antibody CGRP receptor , antibody nerve growth factor ( NGF ) . Are take indomethacin and/or suspect another distinct trigeminal autonomic cephalalgia . A history migraine variant could implicate could confuse ischemia . Known hypersensitivity multiple drug , monoclonal antibody therapeutic protein . A history presence medical illness indicate medical problem would preclude study participation . Evidence significant active unstable psychiatric disease , opinion investigator . Women pregnant nursing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>